We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$1.92B
AUM Growth
-$382M
Cap. Flow
-$14.9M
Cap. Flow %
-0.78%
Top 10 Hldgs %
45.28%
Holding
275
New
41
Increased
31
Reduced
101
Closed
38

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$24.8M
2
ASTH icon
Astrana Health
ASTH
+$16.6M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Top Sells

Rank Stock Value
1
UWMC icon
UWM Holdings
UWMC
+$30.9M
2
WDC icon
Western Digital
WDC
+$24.7M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.6M
4
SUNC
SunocoCorp LLC
SUNC
+$11.6M
5
GXO icon
GXO Logistics
GXO
+$10.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.73%
2 Healthcare 23.91%
3 Consumer Discretionary 7.8%
4 Financials 6.79%
5 Industrials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PURR
76
Hyperliquid Strategies Inc
PURR
$2.3B
$4.33M 0.23%
850,000
-740,000
-47% -$3.35M
VKTX icon
77
Viking Therapeutics
VKTX
$3.75B
$4.23M 0.22%
130,000
-52,000
-29% -$1.67M
TBPH icon
78
Theravance Biopharma
TBPH
$885M
$4.06M 0.21%
+250,000
New +$4.42M
RNA
79
Atrium Therapeutics
RNA
$233M
$4.01M 0.21%
+300,000
New +$4.21M
CZR icon
80
Caesars Entertainment
CZR
$6.06B
$3.96M 0.21%
150,000
-94,000
-39% -$2.24M
MREO
81
Mereo BioPharma
MREO
$40.3M
$3.96M 0.21%
12,000,000
-3,025,000
-20% -$1.3M
LULU icon
82
PUT
lululemon athletica
LULU
$13.7B
$3.83M 0.2%
25,000
– –
SAAQ
83
Space Asset Acquisition Corp
SAAQ
$317M
$3.73M 0.19%
+375,000
New +$3.73M
NVGS icon
84
Navigator Holdings
NVGS
$1.36B
$3.6M 0.19%
186,000
– –
ABEO icon
85
Abeona Therapeutics
ABEO
$339M
$3.45M 0.18%
770,000
– –
BNED icon
86
Barnes & Noble Education
BNED
$415M
$3.36M 0.18%
380,000
+30,000
+9% +$259K
IVVD icon
87
Invivyd
IVVD
$284M
$3.27M 0.17%
2,515,000
-385,000
-13% -$707K
GUTS icon
88
Fractyl Health
GUTS
$105M
$3.08M 0.16%
6,727,235
+679,615
+11% +$627K
CRESY
89
Cresud
CRESY
$784M
$3.05M 0.16%
240,000
-183,552
-43% -$2.23M
COIN icon
90
PUT
Coinbase
COIN
$47.1B
$2.97M 0.15%
17,000
-35,500
-68% -$6.99M
IFRX icon
91
InflaRx
IFRX
$329M
$2.96M 0.15%
3,315,000
– –
IMUX icon
92
Immunic
IMUX
$210M
$2.72M 0.14%
+245,000
New +$2.19M
RXO icon
93
RXO
RXO
$3.61B
$2.63M 0.14%
180,000
-177,953
-50% -$2.61M
ALDX icon
94
Aldeyra Therapeutics
ALDX
$89.9M
$2.53M 0.13%
1,500,000
-30,000
-2% -$131K
LAFA
95
LaFayette Acquisition Corp
LAFA
$2.49M 0.13%
250,000
– –
CNTB
96
Connect Biopharma Holdings
CNTB
$140M
$2.36M 0.12%
+900,000
New +$2.35M
IOVA icon
97
PUT
Iovance Biotherapeutics
IOVA
$3.63B
$2.26M 0.12%
+644,300
New +$2.06M
HHH icon
98
Howard Hughes
HHH
$3.87B
$2.25M 0.12%
35,500
-2,500
-7% -$187K
PANL icon
99
Pangaea Logistics
PANL
$528M
$2.19M 0.11%
309,500
-185,500
-37% -$1.46M
NTGR icon
100
NETGEAR
NTGR
$573M
$2.18M 0.11%
+100,000
New +$2.16M
2 3
4
5 6

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $2.04B AUM 40.78% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $2.04B AUM 33.06% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

683 Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, 683 Capital Management held 275 positions worth $1.92B, down 17% from $2.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management's Q1 2026 filing shows 41 new, 31 increased, 101 reduced and 38 closed positions. Its largest new stake was Astrana Health: 700,000 shares worth $17.2M. The largest sale was UWM Holdings, an estimated $30.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 50% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • 683 Capital Management's largest Q1 2026 buy was Astrana Health: 700,000 shares worth $17.2M.
  • 683 Capital Management added most to Becton Dickinson in Q1 2026, an estimated $24.8M increase.
  • 683 Capital Management's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $10.6M.
  • 683 Capital Management fully exited UWM Holdings in Q1 2026, selling an estimated $30.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $1.92B portfolio in Q1 2026.
  • 683 Capital Management opened 41 new positions and closed 38 in Q1 2026.
  • 683 Capital Management's portfolio value fell 17% quarter-over-quarter to $1.92B.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.